PET and PET/CT in the Diagnosis and Staging of Esophageal and Gastric Cancers

Jeremy J. Erasmus; Eric M. Rohren; Roland Hustinx

doi:10.1016/j.cpet.2008.09.002

PET and PET/CT in the Diagnosis and Staging of Esophageal and Gastric Cancers

Jeremy J. Erasmus, Eric M. Rohren, Roland Hustinx

Nuclear Medicine

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Esophageal and gastric cancers are among the leading causes of cancer-related deaths worldwide. Determining stage of disease at presentation is important in the selection of appropriate management. PET and integrated PET/CT are increasingly being used to initially stage patients who have esophageal and gastric cancers. Although PET has a limited role in the evaluation of the primary tumor and in the detection of locoregional nodal metastases, it is important in the detection of distant metastases. This article reviews the role of PET and PET/CT imaging in the diagnosis, initial staging, and detection of recurrent disease in patients who have esophageal and gastric cancers and elucidates the appropriate use of PET and PET/CT in determining the T, N, and M descriptors of the American Joint Commission on Cancer's guidelines for pathologic and clinical staging.

Original language	English (US)
Pages (from-to)	135-145
Number of pages	11
Journal	PET Clinics
Volume	3
Issue number	2
DOIs	https://doi.org/10.1016/j.cpet.2008.09.002
State	Published - Apr 2008

Keywords

Esophageal cancer
FDG
Gastric cancer
PET-CT

ASJC Scopus subject areas

Radiation
Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.cpet.2008.09.002

Cite this

@article{f7a6b1983dad4458821d54c067424ef2,

title = "PET and PET/CT in the Diagnosis and Staging of Esophageal and Gastric Cancers",

abstract = "Esophageal and gastric cancers are among the leading causes of cancer-related deaths worldwide. Determining stage of disease at presentation is important in the selection of appropriate management. PET and integrated PET/CT are increasingly being used to initially stage patients who have esophageal and gastric cancers. Although PET has a limited role in the evaluation of the primary tumor and in the detection of locoregional nodal metastases, it is important in the detection of distant metastases. This article reviews the role of PET and PET/CT imaging in the diagnosis, initial staging, and detection of recurrent disease in patients who have esophageal and gastric cancers and elucidates the appropriate use of PET and PET/CT in determining the T, N, and M descriptors of the American Joint Commission on Cancer's guidelines for pathologic and clinical staging.",

keywords = "Esophageal cancer, FDG, Gastric cancer, PET-CT",

author = "Erasmus, {Jeremy J.} and Rohren, {Eric M.} and Roland Hustinx",

year = "2008",

month = apr,

doi = "10.1016/j.cpet.2008.09.002",

language = "English (US)",

volume = "3",

pages = "135--145",

journal = "PET Clinics",

issn = "1556-8598",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - PET and PET/CT in the Diagnosis and Staging of Esophageal and Gastric Cancers

AU - Erasmus, Jeremy J.

AU - Rohren, Eric M.

AU - Hustinx, Roland

PY - 2008/4

Y1 - 2008/4

N2 - Esophageal and gastric cancers are among the leading causes of cancer-related deaths worldwide. Determining stage of disease at presentation is important in the selection of appropriate management. PET and integrated PET/CT are increasingly being used to initially stage patients who have esophageal and gastric cancers. Although PET has a limited role in the evaluation of the primary tumor and in the detection of locoregional nodal metastases, it is important in the detection of distant metastases. This article reviews the role of PET and PET/CT imaging in the diagnosis, initial staging, and detection of recurrent disease in patients who have esophageal and gastric cancers and elucidates the appropriate use of PET and PET/CT in determining the T, N, and M descriptors of the American Joint Commission on Cancer's guidelines for pathologic and clinical staging.

AB - Esophageal and gastric cancers are among the leading causes of cancer-related deaths worldwide. Determining stage of disease at presentation is important in the selection of appropriate management. PET and integrated PET/CT are increasingly being used to initially stage patients who have esophageal and gastric cancers. Although PET has a limited role in the evaluation of the primary tumor and in the detection of locoregional nodal metastases, it is important in the detection of distant metastases. This article reviews the role of PET and PET/CT imaging in the diagnosis, initial staging, and detection of recurrent disease in patients who have esophageal and gastric cancers and elucidates the appropriate use of PET and PET/CT in determining the T, N, and M descriptors of the American Joint Commission on Cancer's guidelines for pathologic and clinical staging.

KW - Esophageal cancer

KW - FDG

KW - Gastric cancer

KW - PET-CT

UR - http://www.scopus.com/inward/record.url?scp=64749100464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64749100464&partnerID=8YFLogxK

U2 - 10.1016/j.cpet.2008.09.002

DO - 10.1016/j.cpet.2008.09.002

M3 - Review article

C2 - 27156458

AN - SCOPUS:64749100464

SN - 1556-8598

VL - 3

SP - 135

EP - 145

JO - PET Clinics

JF - PET Clinics

IS - 2

ER -

PET and PET/CT in the Diagnosis and Staging of Esophageal and Gastric Cancers

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this